CLINICAL_TRIALS
trial_result
· 2010-12-06
Clinical Trial Update: Safety and Efficacy Study of MK0974 in the Acute Migraine (0974-016) [Phase 3]
Summary
Phase 3 safety and efficacy study of MK0974 (telcagepant) for acute migraine has completed, with results posted on 2010-12-06.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2010-12-06